PLX51107: Clinical Trials

1 trial of PLX51107, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow PLX51107: new trials by email Literature Review of PLX51107 trials Research Report on PLX51107

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD
BRD4 Inhibitor PLX51107 - Acute Graft Versus Host Disease, Steroid Refractory Graft Versus Host Disease
Phase 1 / Phase 2TerminatedHannah Choe, MD22022-04-192025-01-28

Sponsors

Hannah Choe, MD (1)

Countries

United States (1)

Top investigators

Hannah Choe, MD (1)

Results publications

PMID 38775157

NIH funding

R01CA252469 (1)